Skip to main content
SpringerLink
Log in

High prevalence of three prothrombotic polymorphisms among Palestinians: factor V G1691A, factor II G20210A and methylenetetrahydrofolate reductase C677T

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

Factor V leiden G1691A/R506Q (FVL), prothrombin G20210A (FII) and methylenetetrahydrofolate reductase (MTHFR) C677T are related genetic risk factors for venous thromboembolism. Analysis for those mutations is increasingly being performed on patients exhibiting hypercoagulability. The objective of this study was to determine the prevalence of FVL, FII-G20210A and MTHFR-C677T polymorphisms and their coexistence among apparently healthy Palestinians. After institutional approval, 303 apparently healthy students from An-Najah University representative to North and South regions of West Bank with no previous history of cardiovascular diseases participated in this study. A uniform questionnaire was used to collect relevant information through personal interview with the subjects. The collected information included gender, age, smoking habits, weight and height, diseases such as diabetes, cardiovascular and family history of CVD. The frequencies of allelic distribution of the three prothrombotic polymorphisms factor V G1691A/R506Q), prothrombin G2010A, and MTHFR-C677T were 0.114, 0.050 and 0.071, respectively. The prevalence of the three thrombotic polymorphisms (FVL, FII G20210A and MTHFR-C677T) were 20.1, 9.1 and 13.8 %, respectively. Statistical analysis for factor V leiden showed no significant association between place of residence (P value = 0.953) and gender (P value >0.082). The data presented in this study showed the highest prevalence of FVL among healthy Palestinians compared to other populations and this important finding should be followed in terms of clinical significance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Dahlbäck B (2008) Advances in understanding pathogenic mechanisms of thrombophilic disorders. Blood 112(1):19–27

    Article  PubMed  Google Scholar 

  2. Walker JD (2000) Thrombophilia in pregnancy. J Clin Pathol 53(8):570–573

    Article  Google Scholar 

  3. Bertina RM, Koeleman BP, Koster T et al (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64–67

    Article  PubMed  CAS  Google Scholar 

  4. Finan R, Tamim H, Ameen G et al (2002) Prevalence of factor VG1691A (factor V-leiden) and prothrombin gene mutations in a recurrent miscarriage population. Am J Hematol 71:300–305

    Article  PubMed  CAS  Google Scholar 

  5. Martinelli I, Taioli E, Cetin I, Marinoni A, Gerosa S, Villa MV, Bozzo M, Mannucci PM (2000) Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med 343(14):1015–1018

    Article  PubMed  CAS  Google Scholar 

  6. Isotalo PA, Wells GA, Donnelly JG (2000) Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: an examination of C677T and A1298C mutations. Am J Hum Genet 67(4):986–990

    Article  PubMed  CAS  Google Scholar 

  7. Lensen R, Rosendaal F, Vandenbroucke J, Bertina R (2000) Factor V leiden: the venous thrombotic risk in thrombophilic families. Br J Haematol 110(4):939–945

    Article  PubMed  CAS  Google Scholar 

  8. Kist WJ, Janssen NG, Kalk JJ, Hague WM, Dekker GA, de Vries JL (2008) Thrombophilias and adverse pregnancy outcome—a confounded problem. Thromb Haemostat 99(1):77–85

    CAS  Google Scholar 

  9. Dahlbäck B (1997) Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management. Semin Hematol 34(3):217–234

    PubMed  Google Scholar 

  10. Khan S, Dickerman JD (2006) Hereditary thrombophilia Thromb J 4:15

    Google Scholar 

  11. Rees DC, Cox M, Clegg JB (1995) World distribution of factor V leiden. Lancet 346(8983):1133–1134

    Google Scholar 

  12. Koksal V, Baris I, Etlik O (2007) Primer-engineered multiplex PCR-RFLP for detection of MTHFR C677T, prothrombin G20210A and factor V Leiden mutations. Exp Mol Pathol 83(1):1–3

    Article  PubMed  CAS  Google Scholar 

  13. Husseini A, Abu-Rmeileh NM, Mikki N, Ramahi TM, Ghosh HA, Barghuthi N, Khalili M, Bjertness E, Holmboe-Ottesen G, Jervell J (2009) Cardiovascular diseases, diabetes mellitus, and cancer in the occupied Palestinian territory. Lancet 373(9668):1041–1049

    Article  PubMed  Google Scholar 

  14. Hussein AS, Darwish H, Shelbayeh K (2010) Association between factor V leiden mutation and poor pregnancy outcomes among Palestinian women. Thromb Res 126(2):e78–82

    Article  PubMed  CAS  Google Scholar 

  15. Bathelier C, Champenois T, Lucotte G (1998) ARMS test for diagnosis of factor V leiden mutation and allele frequencies in France. Mol Cell Probes 12:121–123

    Article  PubMed  CAS  Google Scholar 

  16. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88(10):3698–3703

    Google Scholar 

  17. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP et al (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10(1):111–113

    Google Scholar 

  18. Kark JD, Fink R, Adler B, Goldberger N, Goldman S (2006) The incidence of coronary heart disease among Palestinians and Israelis in Jerusalem. Int J Epidemiol 35(2):448–457

    Article  PubMed  Google Scholar 

  19. Cleary-Goldman J, Nakhuda GS, Zimmermann RC, Sauer MV (2003) The role of factor V leiden mutation in recurrent pregnancy loss. J Am Med Womens Assoc 58(3):165–172

    Google Scholar 

  20. Ozmen F, Ozmen MM, Ozalp N, Akar N (2009) The prevalence of factor V (G1691A), MTHFR (C677T) and PT (G20210A) gene mutations in arterial thrombosis. Ulus Travma Acil Cerrahi Derg 15(2):113–119

    Google Scholar 

  21. Dashti AA, Jadaon MM, Abdulsamad AM, Dashti MH, Lewis HL (2011) Thrombosis risk in carriers of the factor V leiden mutation: is it associated with a defined skin color? Pathol Res Pract 207(11):671–673

    Google Scholar 

  22. Almawi WY, Keleshian SH, Borgi L, Fawaz NA, Abboud N, Mtiraoui N, Mahjoub T (2005) Varied prevalence of factor V G1691A (Leiden) and prothrombin G20210A single nucleotide polymorphisms among Arabs. J Thromb Thrombolysis 20(3):163–168

    Google Scholar 

  23. Dashti AA, Jadaon MM (2011) Race differences in the prevalence of the factor V leiden mutation in Kuwaiti nationals. Mol Biol Rep 38(6):3623–3628

    Google Scholar 

  24. Eid SS, Rihani G (2004) Prevalence of factor V leiden, prothrombin G20210A, and MTHFR C677T mutations in 200 healthy Jordanians. Clin Lab Sci 17(4):200–202

    Google Scholar 

  25. Nusier MK, Radaideh AM, Ababneh NA, Qaqish BM, Alzoubi R, Khader Y, Mersa JY, Irshaid NM, El-Khateeb M (2007) Prevalence of factor V G1691A (Leiden) and prothrombin G20210A polymorphisms among apparently healthy Jordanians. Neuro Endocrinol Lett 28(5):699–703

    PubMed  CAS  Google Scholar 

  26. Rosen E, Renbaum P, Heyd J, Levy-Lahad E (1999) High frequency of factor V leiden in a population of Israeli Arabs. Thromb Haemostat 82(6):1768

    Google Scholar 

  27. Settin A, Dowaidar M, El-Baz R, Abd-Al-Samad A, El-Sayed I, Nasr M (2008) Frequency of factor V leiden mutation in Egyptian cases with myocardial infarction. Hematology 13(3):170–174

    Google Scholar 

  28. Akar N, Misirlioğlu M, Akar E, Avcu F, Yalçin A, Sözüöz A (1998) Prothrombin gene 20210 G-A mutation in the Turkish population. Am J Hematol 58(3):249

    Google Scholar 

  29. Almawi WY, Finan RR, Tamim H, Daccache JL, Irani-Hakime N (2004) Differences in the frequency of the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene among the Lebanese population. Am J Hematol 76(1):85–87

    Google Scholar 

Download references

Acknowledgment

We would like to thank Ms Alaa Darwish for her help in this study.

Author information

Authors and Affiliations

  1. Genetics Laboratory, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine

    Ayman S. Hussein

Authors
  1. Ayman S. Hussein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ayman S. Hussein.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hussein, A.S. High prevalence of three prothrombotic polymorphisms among Palestinians: factor V G1691A, factor II G20210A and methylenetetrahydrofolate reductase C677T. J Thromb Thrombolysis 34, 383–387 (2012). https://doi.org/10.1007/s11239-012-0731-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-012-0731-9

Keywords

Search

Navigation